174 related articles for article (PubMed ID: 6323142)
1. Functional receptors for vasoactive intestinal peptide on human osteosarcoma cells.
Hohmann EL; Tashjian AH
Endocrinology; 1984 Apr; 114(4):1321-7. PubMed ID: 6323142
[TBL] [Abstract][Full Text] [Related]
2. Characterization of vasoactive intestinal peptide receptors in human colonic epithelial cells.
Broyart JP; Dupont C; Laburthe M; Rosselin G
J Clin Endocrinol Metab; 1981 Apr; 52(4):715-21. PubMed ID: 6259191
[TBL] [Abstract][Full Text] [Related]
3. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
Zawilska JB; Niewiadomski P; Nowak JZ
Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by intracellular accumulation of cyclic adenosine 3'-5'-monophosphate.
Inoue Y; Kaku K; Kaneko T; Yanaihara N; Kanno T
Endocrinology; 1985 Feb; 116(2):686-92. PubMed ID: 2578385
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive intestinal peptide receptor regulation of cAMP accumulation and glycogen hydrolysis in the human Ewing's sarcoma cell line WE-68.
Van Valen F; Jürgens H; Winkelmann W; Keck E
Cell Signal; 1989; 1(5):435-46. PubMed ID: 2561912
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
Couvineau A; Rousset M; Laburthe M
Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
[TBL] [Abstract][Full Text] [Related]
8. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
9. Receptors for vasoactive intestinal peptide and secretin on small intestinal epithelial cells.
Binder HJ; Lemp GF; Gardner JD
Am J Physiol; 1980 Mar; 238(3):G190-6. PubMed ID: 6245588
[TBL] [Abstract][Full Text] [Related]
10. Importance of the vasoactive intestinal peptide receptor in the stimulation of cyclic adenosine 3',5'-monophosphate in gallbladder epithelial cells of man. Comparison with the guinea pig.
Dupont C; Broyart JP; Broer Y; Chenut B; Laburthe M; Rosselin G
J Clin Invest; 1981 Mar; 67(3):742-52. PubMed ID: 6259209
[TBL] [Abstract][Full Text] [Related]
11. Measurement of cytosolic free Ca2+ concentrations in human and rat osteosarcoma cells: actions of bone resorption-stimulating hormones.
Boland CJ; Fried RM; Tashjian AH
Endocrinology; 1986 Mar; 118(3):980-9. PubMed ID: 3004904
[TBL] [Abstract][Full Text] [Related]
12. Effects of vasoactive intestinal peptide on adenosine 3',5'-monophosphate, ornithine decarboxylase, and cell growth in a human colon cell line.
Yu D; Seitz PK; Selvanayagam P; Rajaraman S; Townsend CM; Cooper CW
Endocrinology; 1992 Sep; 131(3):1188-94. PubMed ID: 1324153
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-I inhibits parathyroid hormone-stimulated and enhances prostaglandin E2-stimulated adenosine 3',5'-monophosphate production by human osteoblast-like SaOS-2 cells.
Goad DL; Tashjian AH
Endocrinology; 1993 Oct; 133(4):1585-92. PubMed ID: 8404598
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
15. IL-1 binds to high affinity receptors on human osteosarcoma cells and potentiates prostaglandin E2 stimulation of cAMP production.
Rodan SB; Wesolowski G; Chin J; Limjuco GA; Schmidt JA; Rodan GA
J Immunol; 1990 Aug; 145(4):1231-7. PubMed ID: 2166111
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
Gespach C; Bawab W; de Cremoux P; Calvo F
Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
Sakakibara H; Shima K; Said SI
Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
[TBL] [Abstract][Full Text] [Related]
18. Interaction of vasoactive intestinal peptide with a cell line (HeLa) derived from human carcinoma of the cervix: binding to specific sites and stimulation of adenylate cyclase.
Prieto JC; Guerrero JM; de Miguel C; Goberna R
Mol Cell Biochem; 1981 Jul; 37(3):167-76. PubMed ID: 6268963
[TBL] [Abstract][Full Text] [Related]
19. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
20. Forskolin-induced homologous desensitization via an adenosine 3',5'-monophosphate-dependent mechanism(s) in human osteoblast-like SaOS-2 cells.
Fukayama S; Tashjian AH; Bringhurst FR
Endocrinology; 1992 Oct; 131(4):1770-6. PubMed ID: 1327719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
